surmount-1 tirzepatide weight loss nondiabetic SURMOUNT-2: confers about 15% in adults with obesity and diabetes SURPASS to SURMOUNT: The Tirzepatide

Its important to monitor how you feel when starting either treatment and report any concerns to your healthcare provider

As the landscape of longevity medicine shifts in 2026, many individuals are moving away from unregulated research chemicals toward medically supervised peptide protocols designed to optimize sleep, body composition, and recovery

If somebodys very metabolically compromised, meaning dosing may apply, the starting standard doses, the approach has been to go very, very slow and low

Clinical trials show that people who maintain their tirzepatide dose keep off 80 to 95 percent of weight lost, while those who stop treatment regain weight within months